GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synairgen PLC (OTCPK:SYGGF) » Definitions » FFO

SYGGF (Synairgen) FFO


View and export this data going back to 2016. Start your Free Trial

What is Synairgen FFO?

FFO (Funds from operations) only applies to REITs.


Synairgen Business Description

Traded in Other Exchanges
Address
Southampton General Hospital, Tremona Road, Mailpoint 810, Level F, South Block, Southampton, GBR, SO16 6YD
Synairgen PLC is a United Kingdom-based respiratory drug discovery and development company. The company is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in areas, including severe asthma, kidney fibrosis, cardiac fibrosis, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The company's Programmes include SNG001, SG016, SG018, and others.